BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 23675295)

  • 1. Volatile metabolites of pathogens: a systematic review.
    Bos LD; Sterk PJ; Schultz MJ
    PLoS Pathog; 2013 May; 9(5):e1003311. PubMed ID: 23675295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.
    Filipiak W; Sponring A; Baur MM; Filipiak A; Ager C; Wiesenhofer H; Nagl M; Troppmair J; Amann A
    BMC Microbiol; 2012 Jun; 12():113. PubMed ID: 22716902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas Chromatography-Mass Spectrometry Profiling of Volatile Metabolites Produced by Some
    Koilybayeva M; Shynykul Z; Ustenova G; Waleron K; Jońca J; Mustafina K; Amirkhanova A; Koloskova Y; Bayaliyeva R; Akhayeva T; Alimzhanova M; Turgumbayeva A; Kurmangaliyeva G; Kantureyeva A; Batyrbayeva D; Alibayeva Z
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005278
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of volatile organic compounds produced from five pathogenic bacteria by headspace-solid phase micro-extraction/gas chromatography-mass spectrometry.
    Chen J; Tang J; Shi H; Tang C; Zhang R
    J Basic Microbiol; 2017 Mar; 57(3):228-237. PubMed ID: 27874211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant/susceptible classification of respiratory tract pathogenic bacteria based on volatile organic compounds profiling.
    Karami N; Rezadoost H; Mirzajani F; Karimi A; Ghassempour A; Aliahmadi A; Fallah F
    Cell Mol Biol (Noisy-le-grand); 2018 Jun; 64(9):6-15. PubMed ID: 30030949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headspace volatile organic compounds from bacteria implicated in ventilator-associated pneumonia analysed by TD-GC/MS.
    Lawal O; Muhamadali H; Ahmed WM; White IR; Nijsen TME; Goodacre R; Fowler SJ
    J Breath Res; 2018 Jan; 12(2):026002. PubMed ID: 28947683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa.
    Shestivska V; Spaněl P; Dryahina K; Sovová K; Smith D; Musílek M; Nemec A
    J Appl Microbiol; 2012 Sep; 113(3):701-13. PubMed ID: 22726261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of volatile metabolites during growth of Escherichia coli and Pseudomonas aeruginosa by needle trap-GC-MS.
    Zscheppank C; Wiegand HL; Lenzen C; Wingender J; Telgheder U
    Anal Bioanal Chem; 2014 Oct; 406(26):6617-28. PubMed ID: 25146358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial Volatiles as Diagnostic Biomarkers of Bacterial Lung Infection in Mechanically Ventilated Patients.
    Ahmed WM; Fenn D; White IR; Dixon B; Nijsen TME; Knobel HH; Brinkman P; Van Oort PMP; Schultz MJ; Dark P; Goodacre R; Felton T; Bos LDJ; Fowler SJ;
    Clin Infect Dis; 2023 Mar; 76(6):1059-1066. PubMed ID: 36310531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.
    Shestivska V; Dryahina K; Nunvář J; Sovová K; Elhottová D; Nemec A; Smith D; Španěl P
    J Breath Res; 2015 Apr; 9(2):027104. PubMed ID: 25830686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TD/GC-MS analysis of volatile markers emitted from mono- and co-cultures of
    Lawal O; Knobel H; Weda H; Nijsen TME; Goodacre R; Fowler SJ;
    Metabolomics; 2018; 14(5):66. PubMed ID: 29725275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volatile organic compounds generated by cultures of bacteria and viruses associated with respiratory infections.
    Abd El Qader A; Lieberman D; Shemer Avni Y; Svobodin N; Lazarovitch T; Sagi O; Zeiri Y
    Biomed Chromatogr; 2015 Dec; 29(12):1783-90. PubMed ID: 26033043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography-mass spectrometry.
    Boots AW; Smolinska A; van Berkel JJ; Fijten RR; Stobberingh EE; Boumans ML; Moonen EJ; Wouters EF; Dallinga JW; Van Schooten FJ
    J Breath Res; 2014 Jun; 8(2):027106. PubMed ID: 24737039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled Volatile Organic Compounds of Infection: A Systematic Review.
    Ahmed WM; Lawal O; Nijsen TM; Goodacre R; Fowler SJ
    ACS Infect Dis; 2017 Oct; 3(10):695-710. PubMed ID: 28870074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast detection of volatile organic compounds from bacterial cultures by secondary electrospray ionization-mass spectrometry.
    Zhu J; Bean HD; Kuo YM; Hill JE
    J Clin Microbiol; 2010 Dec; 48(12):4426-31. PubMed ID: 20962140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro profiling of volatile organic compounds released by Simpson-Golabi-Behmel syndrome adipocytes.
    Mochalski P; Diem E; Unterkofler K; Mündlein A; Drexel H; Mayhew CA; Leiherer A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():256-261. PubMed ID: 30537625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS.
    Filipiak W; Sponring A; Baur MM; Ager C; Filipiak A; Wiesenhofer H; Nagl M; Troppmair J; Amann A
    Microbiology (Reading); 2012 Dec; 158(Pt 12):3044-3053. PubMed ID: 23059976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volatile organic compounds in headspace characterize isolated bacterial strains independent of growth medium or antibiotic sensitivity.
    Hintzen KFH; Blanchet L; Smolinska A; Boumans ML; Stobberingh EE; Dallinga JW; Lubbers T; van Schooten FJ; Boots AW
    PLoS One; 2024; 19(1):e0297086. PubMed ID: 38277384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.